Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

May 31, 2001

UDL Laboratories Inc. Recalls Perphenazine Tablets 

Rockford, IL (SafetyAlerts) - The Food and Drug Administration (FDA) said today that UDL Laboratories, Inc. is recalling certain Perphenazine Tablets because of discoloration of tablets prior to expiry.

This is the first public notice of this Class III recall issued by FDA.

Perphenazine Tablets, USP (Gray)
a) 2 mg. tablets - NDC 51079-738-20 Recall #D-215-1;
b) 4 mg. tablets - NDC 51079-739-20 Recall #D-216-1;
c) 8 mg. tablets - NDC 51079-740-20 Recall #D-217-1;
d) 16 mg. tablets -NDC 51079-823-20 Recall #D-218-1.

Packaged in unit dose blisters 10 unit dose tablets per card, 10 cards per shelf carton.

a) lots 0B224, 0J900, 1A680;
b) lots 0C382, 0J891, 0S474, 1B909;
c) lots 0A067, 0P287;
d) lots 0B119, 0S399.

Zenith Goldline Pharmaceuticals, Northvale, NJ.

UDL Laboratories, Inc., Rockford, IL, by letter dated 5/11/01. Firm-initiated recall ongoing.


a)3939; b) 3894; c) 3541; d) 1183.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers May 31, 2001.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.